早期vigabatrin用于增强GABAergic通路在后麻醉状态的
Carolina B Maciel1, Bakhtawar Ahmad2, Maria Jose Bruzzone Giraldez3
1Department of Neurology, Division of Neurocritical Care, University of Florida College of Medicine, Gainesville, FL 32611, USA; Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Neurology, University of Utah, Salt Lake City, UT 84132, USA.
Epilepsy & behavior : E&B
|October 11, 2024
概括
患有后麻醉状态 (PASE) 患者的结局不佳. 用维加巴早期抑制GABA转氨酶可能通过增强GABAergic通路为PASE提供一种有效的辅助疗法.
科学领域:
- 神经学 神经学
- 神经临界护理是指神经临界护理.
- 药理学 药理学是指药理学的学科.
背景情况:
- 尽管复苏取得了进展,但经历过麻醉后状态 (PASE) 的患者的结果仍然很差.
- 治疗虚无主义和发作折射性有助于PASE的阴暗预后.
- 缺氧-缺血性侮辱通常被排除在临床试验之外,使知识空白延续.
研究的目的:
- 解决迫切需要有效的疗法,以向缺氧缺血性脑损伤中的过度兴奋.
- 探索早期玛-氨基黄油酸 (GABA) 转氨酶抑制作为PASE辅助疗法的潜力.
主要方法:
- 这项研究是基于在第九届伦敦-因斯布鲁克关于 status epilepticus和急性发作的会议上发表的讲座.
- 该前提包括抑制GABA转氨酶以停止GABA分解.
- 这种方法旨在协同增强GABAergic通路.
主要成果:
- 用vigabatrin早期抑制GABA转氨酶显示出作为PASE有效的辅助疗法的潜力.
- 停止GABA降解促进了增强的GABAergic活动.
- 当与积极的GABAergic全调节剂相结合时,可以实现GABAergic通路的协同增强.
结论:
- 维加巴特林为PASE提供了一个有前途的治疗策略.
- 向GABAergic通路提供了一种新的方法来管理后麻醉环境中的发作.
- 对GABA调节疗法的进一步研究是有必要的,以改善PASE的结果.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
338
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
338
01:20Antiepileptic Drugs: Potassium Channel Activators
148
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
148
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
263
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
263
01:14Antiepileptic Drugs: Glutamate Antagonists
287
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
287
01:08Antiepileptic Drugs: Sodium Channel Blockers
442
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
442
01:30Electroconvulsive Therapy
26
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
26